Antagonism of detomidine sedation in the horse using intravenous tolazoline or atipamezole.

The article discusses a study into the effects of atipamezole and tolazoline on shortening the duration of detomidine sedation in horses.

Objective and Purpose of Study

• This research was conducted to determine whether atipamezole and tolazoline could shorten the period of detomidine sedation in horses. Detomidine sedation being a common practice in veterinary medicine, enhancing its safety and usefulness was a primary concern.
• The researchers hypothesized that the administration of either atipamezole or tolazoline would not affect the sedation caused by detomidine in horses.

Methods Employed

• The methodological approach was a randomized, placebo-controlled, double-blind descriptive study.
• A total of 6 mature horses were chosen and administered detomidine on four separate occasions
• 25 minutes post the administration of detomidine, each horse then received one of 4 treatments. Group 1 served as the placebo using saline, while Group 2, Group 3 and Group 4 were given different doses of atipamezole or tolazoline respectively.
• Various characteristics like sedation, muscle relaxation and ataxia levels were measured by 3 independent observers at 9 different times. The horses were also led through an obstacle course and their ability to traverse, as well as the time taken, were scored by observers. The sessions were all video recorded for reference.

Results and Conclusion

• Results indicate that the administration of atipamezole and tolazoline did show an effect in shortening the detomidine sedation time. They failed to completely neutralize the effects of detomidine but the time to recovery was quicker than without them.
• From the findings, the researchers concluded that single bolus administration of atipamezole or tolazoline could be useful in minimizing the duration of detomidine sedation in horses.